Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

PTN

Palatin Technologies (PTN)

Palatin Technologies Inc New
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:PTN
DateTimeSourceHeadlineSymbolCompany
08/08/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
08/08/20237:30AMPR Newswire (US)Palatin's Vyleesi® Licensee Fosun Pharma Reports First Commercial Sale in China and South Korean Licensee Kwangdong Pharmaceuticals Completes Enrollment in Phase 3 Clinical StudyAMEX:PTNPalatin Technologies Inc New
08/07/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
08/07/20237:30AMPR Newswire (US)Palatin Announces Direct-to-Consumer Telehealth Partnership with UpScriptHealth™ for Vyleesi®AMEX:PTNPalatin Technologies Inc New
08/04/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
08/04/20237:30AMPR Newswire (US)Palatin to Participate in Canaccord Genuity's 43rd Annual Growth ConferenceAMEX:PTNPalatin Technologies Inc New
07/11/20238:25AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
07/11/20237:30AMPR Newswire (US)Palatin Announces Preliminary Fourth Quarter Fiscal 2023 Vyleesi® Product Revenue ResultsAMEX:PTNPalatin Technologies Inc New
06/22/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PTNPalatin Technologies Inc New
06/22/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PTNPalatin Technologies Inc New
06/22/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PTNPalatin Technologies Inc New
06/22/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PTNPalatin Technologies Inc New
06/22/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PTNPalatin Technologies Inc New
06/22/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PTNPalatin Technologies Inc New
06/22/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PTNPalatin Technologies Inc New
06/22/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PTNPalatin Technologies Inc New
06/21/20239:02AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:PTNPalatin Technologies Inc New
05/30/20237:30AMPR Newswire (US)Palatin Presents Preclinical Diabetic Nephropathy Data at the International Podocyte ConferenceAMEX:PTNPalatin Technologies Inc New
05/19/20235:17PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PTNPalatin Technologies Inc New
05/16/20238:16AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:PTNPalatin Technologies Inc New
05/16/20237:30AMPR Newswire (US)Palatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate UpdateAMEX:PTNPalatin Technologies Inc New
05/15/20234:27PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:PTNPalatin Technologies Inc New
05/12/20238:44AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:PTNPalatin Technologies Inc New
05/11/20234:15PMPR Newswire (US)Palatin to Report Third Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on May 16, 2023AMEX:PTNPalatin Technologies Inc New
05/09/20238:20AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:PTNPalatin Technologies Inc New
05/09/20237:30AMPR Newswire (US)Palatin Presents PL8177 Ulcerative Colitis Data at Digestive Disease Week Annual ConferenceAMEX:PTNPalatin Technologies Inc New
05/08/20234:04PMPR Newswire (US)Palatin Invites Investors to Listen to Replay of the PL9643 Dry Eye Disease Key Opinion Leader WebinarAMEX:PTNPalatin Technologies Inc New
05/01/20234:00PMPR Newswire (US)Palatin Technologies to Host Key Opinion Leader WebinarAMEX:PTNPalatin Technologies Inc New
04/27/20238:31AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:PTNPalatin Technologies Inc New
04/27/20237:30AMPR Newswire (US)Palatin Presents Initial Dry Eye Disease Phase 3 Clinical Data at the Association of Research in Vision and Ophthalmology 2023 Annual ConferenceAMEX:PTNPalatin Technologies Inc New
 Showing the most relevant articles for your search:AMEX:PTN